320 products were found matching "K04277"!

ADB-BUTINACA-d9 (CRM) (Cay-40385) is intended for use as an internal standard for the quantification of ADB-BUTINACA (Cay-40384, Cay-29350) by GC- or LC-MS. ADB-BUTINACA is categorized as a synthetic cannabinoid. ADB-BUTINACA is regulated as a Schedule I compound in the United States. This product is intended for...

Organism: Rattus norvegicus (Rat). Source: in vitro E.coli expression system. Expression Region: 1-473aa. Protein Length: Full Length. Tag Info: N-terminal 10xHis-tagged. Target Protein Sequence: MKSILDGLAD TTFRTITTDL LYVGSNDIQY EDIKGDMASK LGYFPQKFPL TSFRGSPFQE KMTAGDNSPL VPAGDTTNIT EFYNKSLSSF KENEENIQCG ENFMDMECFM...

Delta9-THC-d3 (CRM) (Cay-41210) is intended for use as an internal standard for the quantification of Delta9-THC (Cay-ISO60157, Cay-12068) by GC- or LC-MS. Delta9-THC is categorized as a cannabinoid. It is psychoactive and has diverse effects on perception, cognition, and pain sensitivity. Delta9-THC is regulated as...

BPR0912 is a cannabinoid 1 (CB1) receptor inverse agonist (IC50 = 8.5 nM for the human receptor). It is selective for CB1 over CB2 receptors (IC50 = 604.9 nM for the human receptor). In vivo, BPR0912 (10 mg/kg per day) inhibits diet-induced increases in body weight, epididymal and inguinal fat pad mass, and serum...

N-Arachidonoyl dopamine (NADA) is an arachidonoyl amino acid and cannabinoid (CB) receptor 1 agonist (Ki = 250 nM in rat brain membranes, which highly express CB1 receptors). It is selective for CB1 over CB2 receptors (Ki = 12,000 nM in rat spleen membranes, which highly express CB2 receptors). NADA induces...

AM251 is a cannabinoid 1 (CB1) receptor 1 antagonist. It binds to CB1 receptors in rat forebrain membrane preparations (Ki = 7.5 nM) and is selective over CB2 receptors in mouse spleen preparations (Ki = 2,290 nM) in radioligand binding assays. AM251 inhibits GTPgammaS binding induced by the CB receptor agonist CP...

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Rat CNR1. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Rat CNR1. Next,...

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human CNR1. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human CNR1. Next,...

The CB1 receptor is a G-protein coupled receptor that binds the active component of cannabis, Delta9-tetrahydrocannabinol. This antibody has been raised against the C-terminal (amino acids 461-472) intracellular region of the human CB1 receptor and can be used for western blotting. Human and rat CB1 receptors...

The CB1 receptor and the splice variant CB1a are localized mainly in the brain. The CB1 receptor is a G-protein coupled receptor that binds the active component of cannabis, Delta9-tetrahydrocannabinol. Human and rat CB1 receptors exhibit 97.3% homology at the amino acid level over the complete protein, and 100%...

Rimonabant is a cannabinoid 1 (CB1) receptor antagonist (Ki = 5.6 nM). It is selective for CB1 over CB2 receptors (Ki = >1,000 nM), as well as a panel of 37 other receptors and channels (IC50s = >1,000 nM). Rimonabant (10 µM) inhibits phytohemagglutinin-induced proliferation of isolated human peripheral blood...

9(R)-Hexahydrocannabinol (CRM) (Cay-37913) is a certified reference material that is structurally similar to known phytocannabinoids. 9(R)-Hexahydrocannabinol induces immobility, severe stupor, ataxia, full ptosis, and crouched posture, markers of psychotropic activity, in rhesus monkeys. This product is intended...